Transcription factor Olig2 defines subpopulations of retinal progenitor cells biased toward specific cell fates
Previous lineage analyses have shown that retinal progenitor cells (RPCs) are multipotent throughout development, and expression-profiling studies have shown a great deal of molecular heterogeneity among RPCs. To determine if the molecular heterogeneity predicts that an RPC will produce particular t...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 109; no. 20; pp. 7882 - 7887 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
15-05-2012
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Previous lineage analyses have shown that retinal progenitor cells (RPCs) are multipotent throughout development, and expression-profiling studies have shown a great deal of molecular heterogeneity among RPCs. To determine if the molecular heterogeneity predicts that an RPC will produce particular types of progeny, clonal lineage analysis was used to investigate the progeny of a subset of RPCs, those that express the basic helix–loop–helix transcription factor, Olig2. The embryonic Olig2+ RPCs underwent terminal divisions, producing small clones with primarily two of the five cell types being made by the pool of RPCs at that time. The later, postnatal Olig2+ RPCs also made terminal divisions, which were biased toward production of rod photoreceptors and amacrine cell interneurons. These data indicate that the multipotent progenitor pool is made up of distinctive types of RPCs, which have biases toward producing subsets of retinal neurons in a terminal division, with the types of neurons produced varying over time. This strategy is similar to that of the developing Drosophila melanogaster ventral nerve cord, with the Olig2+ cells behaving as ganglion mother cells. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1203138109 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 4Present address: Department of Genetics, Development and Cell Biology, Iowa State University, Ames, IA 50011. 3Present address: Department of Ophthalmology and Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01606. Contributed by Constance L. Cepko, March 9, 2012 (sent for review September 30, 2011) 1B.P.H. and N.S. contributed equally to this work. 2Present address: Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT 06510. Author contributions: C.L.C. designed research; B.P.H., N.S., K.T.B., C.P., J.M.T., and J.H.K. performed research; B.P.H., N.S., and C.L.C. analyzed data; and B.P.H. and C.L.C. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1203138109 |